From islet transplantation to beta-cell regeneration: an update on beta-cell-based therapeutic approaches in type 1 diabetes

References

• Yoon JW, Jun HS. Autoimmune destruction of pancreatic beta cells. Am J Ther. 2005 Nov;12(6):580–591. doi: 10.1097/01.mjt.0000178767.67857.63
   PubMedGoogle Scholar
• Pinnaro MJT CT. Hypoglycemia in the diabetes control and complications trial. Diabetes. 1997;46(2):271–286.
   PubMed Web of Science ®Google Scholar
• Klonoff DC. Afrezza inhaled insulin: the fastest-acting FDA-approved insulin on the market has favorable properties. Los Angeles (CA): SAGE Publications Sage CA; 2014. p. 1071–1073.
   Google Scholar
• Mohanty RR, Das S. Inhaled insulin-current direction of insulin research. J Clin Diagn Res. 2017;11(4):OE01. doi: 10.7860/JCDR/2017/23626.9732
   PubMedGoogle Scholar
• ChristiansenmpBode BW2 BT, Christiansen MP, Klaff LJ, et al. The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther. 2015;17:787.
   PubMed Web of Science ®Google Scholar
• Fioretto P, Steffes MW, Sutherland DE, et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339(2):69–75. doi: 10.1056/NEJM199807093390202
   PubMed Web of Science ®Google Scholar
• Pieroni E, Napoli N, Lombardo C, et al. Duodenal graft complications requiring duodenectomy after pancreas and pancreas–kidney transplantation. Am J Transplant. 2018;18(6):1388–1396. doi: 10.1111/ajt.14613
   PubMed Web of Science ®Google Scholar
• Dholakia S, Oskrochi Y, Easton G, et al. Advances in pancreas transplantation. J R Soc Med. 2016;109(4):141–146. doi: 10.1177/0141076816636369
   PubMed Web of Science ®Google Scholar
• Camilla Leal Lopes da S. Terapias alternativas para o diabetes mellitus tipo 1: caracterização funcional do gene Txnip na diferenciação b -pancreática e desenvolvimento de biomaterial inovador para microencapsulamento celular. São Paulo: Universidade de São Paulo; 2018.
   Google Scholar
• Hering BJ, Clarke WR, Bridges ND, et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care. 2016;39(7):1230–1240. doi: 10.2337/dc15-1988
   PubMed Web of Science ®Google Scholar
• Leal‐Lopes C, Grazioli G, Mares‐Guia TR, et al. Polymerized laminin incorporation into alginate‐based microcapsules reduces pericapsular overgrowth and inflammation. J Tissue Eng Regen Med. 2019;13(10):1912–1922. doi: 10.1002/term.2942
   PubMed Web of Science ®Google Scholar
• Shapiro A, Pokrywczynska M, Ricordi C. Clinical pancreatic islet transplantation. Nat Rev Endocrinol. 2017;13(5):268–277. doi: 10.1038/nrendo.2016.178
   PubMed Web of Science ®Google Scholar
• Shapiro A. State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diab Rep. 2011;11(5):345–354. doi: 10.1007/s11892-011-0217-8
   PubMed Web of Science ®Google Scholar
• Abu-El-Haija M, Anazawa T, Beilman GJ, et al. The role of total pancreatectomy with islet autotransplantation in the treatment of chronic pancreatitis: a report from the international consensus guidelines in chronic pancreatitis. Pancreatology. 2020;20(4):762–771. doi: 10.1016/j.pan.2020.04.005
   PubMed Web of Science ®Google Scholar
• Berney T, Andres A, Bellin MD, et al. A worldwide survey of activities and practices in clinical islet of langerhans transplantation. Transplant Int. 2022;35:10507. doi: 10.3389/ti.2022.10507
   PubMed Web of Science ®Google Scholar
• Othonos N, Choudhary P. Who should be considered for islet transplantation alone? Curr Diab Rep. 2017;17(4):1–7. doi: 10.1007/s11892-017-0847-6
   PubMed Web of Science ®Google Scholar
• McCall M, Shapiro AJ, editors. Islet cell transplantation. Seminars in pediatric surgery. Elsevier; 2014.
   Google Scholar
• Lacy PE. The pancreatic beta cell. Structure and function. N Engl J Med. 1967 Jan 26;276(4):187–195.
   PubMed Web of Science ®Google Scholar
• Marchetti P, Ferrannini E. β‐Cell mass and function in human type 2 diabetes. Intern Textbook Diabetes Mellit. UK: Wiley Blackwell; 2015. p. 354–370. doi: 10.1002/9781118387658.ch24
   Google Scholar
• Handorf HWS AM, Alam T, Alam T. Genetic engineering of surrogate β cells for treatment of type 1 diabetes mellitus. J Diabetes Mellit. 2015;5(4):295–312. doi: 10.4236/jdm.2015.54037
   Google Scholar
• Newgard CB, McGarry JD. Metabolic coupling factors in pancreatic β-cell signal transduction. Annu Rev Biochem. 1995;64(1):689–719. doi: 10.1146/annurev.bi.64.070195.003353
   PubMedGoogle Scholar
• Davidson HW, Peshavaria M, Hutton JC. Proteolytic conversion of Proinsulin into insulin - identification of a Ca-2±Dependent acidic endopeptidase in isolated insulin-secretory granules. Biochem J. 1987 Sep 1;246(2):279–286. doi: 10.1042/bj2460279
   PubMed Web of Science ®Google Scholar
• Nielsen JH, Galsgaard ED, Moldrup A, et al. Regulation of beta-cell mass by hormones and growth factors. Diabetes. 2001 Feb;50 Suppl 1:(suppl_1):S25–9.
   PubMedGoogle Scholar
• Meier JJ, Butler AE, Saisho Y, et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes. 2008 Jun;57:(6):1584–1594.
   PubMed Web of Science ®Google Scholar
• Murtaugh LC, Melton DA. Genes, signals, and lineages in pancreas development. Annu Rev Cell Dev Biol. 2003;19(1):71–89. doi: 10.1146/annurev.cellbio.19.111301.144752
   PubMedGoogle Scholar
• Zaret KS, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science. 2008 Dec 5;322(5907):1490–1494.
   PubMed Web of Science ®Google Scholar
• Edlund H. Pancreatic organogenesis - developmental mechanisms and implications for therapy. Nat Rev Genet. 2002 Jul;3(7):524–532. doi: 10.1038/nrg841
   PubMed Web of Science ®Google Scholar
• Desgraz R, Herrera PL. Pancreatic neurogenin 3-expressing cells are unipotent islet precursors. Development. 2009 Nov;136(21):3567–3574. doi: 10.1242/dev.039214
   PubMed Web of Science ®Google Scholar
• Reers C, Erbel S, Esposito I, et al. Impaired islet turnover in human donor pancreata with aging. Eur J Endocrinol. 2009 Feb;160:(2):185–191.
   PubMed Web of Science ®Google Scholar
• Bernal-Mizrachi E, Kulkarni RN, Scott DK, et al. Human beta-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map. Diabetes. 2014 Mar;63:(3):819–831.
   PubMed Web of Science ®Google Scholar
• Vetere A, Wagner BK. Chemical methods to induce beta-cell proliferation. Int j endocrinol. 2012;2012:1–8. doi: 10.1155/2012/925143
   Web of Science ®Google Scholar
• Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, et al. Molecular control of cell cycle progression in the pancreatic beta-cell. Endocr Rev. 2006 Jun;27:(4):356–370.
   PubMed Web of Science ®Google Scholar
• Heit JJ, Karnik SK, Kim SK. Intrinsic regulators of pancreatic β-cell proliferation. Annu Rev Cell Dev Biol. 2006;22(1):311–338. doi: 10.1146/annurev.cellbio.22.010305.104425
   PubMedGoogle Scholar
• Shcheglova E, Blaszczyk K, Borowiak M. Mitogen synergy: an emerging route to boosting human beta cell proliferation. Front Cell Dev Biol. 2022;9:2551. doi:10.3389/fcell.2021.734597
   Google Scholar
• Kulkarni RN, Mizrachi E-B, Ocana AG, et al. Human β-cell proliferation and intracellular signaling: driving in the dark without a road map. Diabetes. 2012;61(9):2205–2213. doi: 10.2337/db12-0018
   PubMed Web of Science ®Google Scholar
• Eguchi N, Toribio AJ, Alexander M, et al. Dysregulation of β-cell proliferation in diabetes: possibilities of combination therapy in the development of a comprehensive treatment. Biomedicines. 2022;10(2):472. doi: 10.3390/biomedicines10020472
   PubMed Web of Science ®Google Scholar
• Hu Q, Mu J, Liu Y, et al. Obesity-induced miR-455 upregulation promotes adaptive pancreatic β-cell proliferation through the CPEB1/CDKN1B pathway. Diabetes. 2022;71(3):394–411. doi: 10.2337/db21-0134
   PubMed Web of Science ®Google Scholar
• Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol. 2001;17(1):387–403. doi: 10.1146/annurev.cellbio.17.1.387
   PubMedGoogle Scholar
• D’Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnol. 2006 Nov;24:(11):1392–1401.
   PubMed Web of Science ®Google Scholar
• Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nature Biotechnol. 2008 Apr;26:(4):443–452.
   PubMed Web of Science ®Google Scholar
• Rezania A, Bruin JE, Arora P, et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol. 2014 Nov;32:(11):1121–1133.
   PubMed Web of Science ®Google Scholar
• Pagliuca FW, Millman JR, Gürtler M, et al. Generation of functional human pancreatic β cells in vitro. Cell. 2014;159(2):428–439. doi: 10.1016/j.cell.2014.09.040
   PubMed Web of Science ®Google Scholar
• Incorporated VP. Vertex announces FDA clearance of investigational new drug (IND) application for VX-880, a novel cell therapy for the treatment of type 1 diabetes (T1D) USA: vertex pharmaceuticals incorporated. 2021 [cited 2021 May 31]. Available from: https://news.vrtx.com/press-release/vertex-announces-fda-clearance-investigational-new-drug-ind-application-vx-880-novel
   Google Scholar
• Partridge M, Eustace B, Pai M. Vertex announces positive day 90 data for the first patient in the phase 1/2 clinical trial dosed with VX‐880, a novel investigational stem cell‐derived therapy for the treatment of type 1 diabetes. Vertex Pharmaceuticals Incorporated; 2021.
   Google Scholar
• Kelly OG, Chan MY, Martinson LA, et al. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nature Biotechnol. 2011;29(8):750–756. doi: 10.1038/nbt.1931
   PubMed Web of Science ®Google Scholar
• Bocian-Sobkowska J, Zabel M, Wozniak W, et al. Polyhormonal aspect of the endocrine cells of the human fetal pancreas. Histochem Cell Biol. 1999;112(2):147–153. doi: 10.1007/s004180050401
   PubMed Web of Science ®Google Scholar
• Nair GG, Liu JS, Russ HA, et al. Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived β cells. Nat Cell Biol. 2019;21(2):263–274. doi: 10.1038/s41556-018-0271-4
   PubMed Web of Science ®Google Scholar
• Velazco-Cruz L, Song J, Maxwell KG, et al. Acquisition of dynamic function in human stem cell-derived β cells. Stem Cell Rep. 2019;12(2):351–365. doi: 10.1016/j.stemcr.2018.12.012
   PubMed Web of Science ®Google Scholar
• Takaichi S, Tomimaru Y, Akagi T, et al. Three-dimensional vascularized β-cell spheroid tissue derived from human induced pluripotent stem cells for subcutaneous islet transplantation in a mouse model of type 1 diabetes. Transplantation. 2022;106(1):48–59. doi: 10.1097/TP.0000000000003745
   PubMed Web of Science ®Google Scholar
• Zhang C, Moriguchi T, Kajihara M, et al. MafA is a key regulator of glucose-stimulated insulin secretion. Mol Cell Biol. 2005; Jun25:(12):4969–4976.
   PubMed Web of Science ®Google Scholar
• Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000 Jul 27;343(4):230–238. doi: 10.1056/NEJM200007273430401
   PubMed Web of Science ®Google Scholar
• Kirk K, Hao E, Lahmy R, et al. Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape. Stem Cell Res. 2014;12(3):807–814. doi: 10.1016/j.scr.2014.03.003
   PubMed Web of Science ®Google Scholar
• Burke J, Zhang X, Frey MA, et al. 209.8: subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability. Transplantation. 2021;105(12S1):S17. doi: 10.1097/01.tp.0000804368.25112.4d
   Google Scholar
• Pepper AR, Pawlick R, Bruni A, et al. Transplantation of human pancreatic endoderm cells reverses diabetes post transplantation in a prevascularized subcutaneous site. Stem Cell Rep. 2017;8(6):1689–1700. doi: 10.1016/j.stemcr.2017.05.004
   PubMed Web of Science ®Google Scholar
• Van Lummel M, Van Veelen PA, De Ru AH, et al. Dendritic cells guide islet autoimmunity through a restricted and uniquely processed peptidome presented by high-risk HLA-DR. J Immunol. 2016;196(8):3253–3263. doi: 10.4049/jimmunol.1501282
   PubMed Web of Science ®Google Scholar
• Coronel M, Liang J-P, Li Y, et al. Oxygen generating biomaterial improves the function and efficacy of beta cells within a macroencapsulation device. Biomaterials. 2019;210:1–11. doi: 10.1016/j.biomaterials.2019.04.017
   PubMed Web of Science ®Google Scholar
• Liang J-P, Accolla RP, Soundirarajan M, et al. Engineering a macroporous oxygen-generating scaffold for enhancing islet cell transplantation within an extrahepatic site. Acta Biomaterialia. 2021;130:268–280. doi: 10.1016/j.actbio.2021.05.028
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Sekine K, Kin T, et al. Self-condensation culture enables vascularization of tissue fragments for efficient therapeutic transplantation. Cell Rep. 2018;23(6):1620–1629. doi: 10.1016/j.celrep.2018.03.123
   PubMed Web of Science ®Google Scholar
• Russ HA, Bar Y, Ravassard P, et al. In vitro proliferation of cells derived from adult human β-cells revealed by cell-lineage tracing. Diabetes. 2008;57(6):1575–1583. doi: 10.2337/db07-1283
   PubMed Web of Science ®Google Scholar
• Joglekar MV, Joglekar VM, Joglekar SV, et al. Human fetal pancreatic insulin-producing cells proliferate in vitro. J Endocrinol. 2009;201(1):27. doi: 10.1677/JOE-08-0497
   PubMed Web of Science ®Google Scholar
• Bensellam M, Jonas J-C, Laybutt DR. Mechanisms of β-cell dedifferentiation in diabetes: recent findings and future research directions. J Endocrinol. 2018;236(2):R109–R143. doi: 10.1530/JOE-17-0516
   PubMed Web of Science ®Google Scholar
• Balboa D, Barsby T, Lithovius V, et al. Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nature Biotechnol. 2022;40:1042–1055. doi: 10.1038/s41587-022-01219-z
   PubMed Web of Science ®Google Scholar
• Stoffers DA, Zinkin NT, Stanojevic V, et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet. 1997 Jan;15:(1):106–110.
   PubMed Web of Science ®Google Scholar
• Holland AM, Hale MA, Kagami H, et al. Experimental control of pancreatic development and maintenance. Proc Natl Acad Sci USA. 2002 Sep 17;99(19):12236–12241. doi: 10.1073/pnas.192255099
   PubMed Web of Science ®Google Scholar
• Li SW, Koya V, Li Y, et al. Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes. Lab Invest. 2010 Jan;90:(1):31–39.
   PubMed Web of Science ®Google Scholar
• Matsuoka TA, Artner I, Henderson E, et al. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2930–2933. doi: 10.1073/pnas.0306233101
   PubMed Web of Science ®Google Scholar
• Aguayo-Mazzucato C, Koh A, El Khattabi I, et al. Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells. Diabetologia. 2011 Mar;54:(3):583–593.
   PubMed Web of Science ®Google Scholar
• Collombat P, Mansouri A, Hecksher-Sorensen J, et al. Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes Dev. 2003 Oct 15;17(20):2591–2603. doi: 10.1101/gad.269003
   PubMed Web of Science ®Google Scholar
• Sosa-Pineda B, Chowdhury K, Torres M, et al. The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature. 1997 Mar 27;386(6623):399–402. doi: 10.1038/386399a0
   PubMed Web of Science ®Google Scholar
• Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008 Oct 2;455(7213):627–632. doi: 10.1038/nature07314
   PubMed Web of Science ®Google Scholar
• Li W, Cavelti-Weder C, Zhang Y, et al. Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells. Nat Biotechnol. 2014 Dec;32:(12):1223–1230.
   PubMed Web of Science ®Google Scholar
• Lee J, Sugiyama T, Liu Y, et al. Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells. Elife. 2013 Nov 19;2:e00940.
   PubMed Web of Science ®Google Scholar
• Chakravarthy H, Gu X, Enge M, et al. Converting adult pancreatic islpha cells into beta cells by targeting both Dnmt1 and Arx. Cell Metab. 2017 Mar 7;25(3):622–634. doi: 10.1016/j.cmet.2017.01.009
   PubMed Web of Science ®Google Scholar
• Herrera PL. Adult insulin-and glucagon-producing cells differentiate from two independent cell lineages. Development. 2000;127(11):2317–2322. doi: 10.1242/dev.127.11.2317
   PubMed Web of Science ®Google Scholar
• Bonal C, Herrera PL. Genes controlling pancreas ontogeny. Int J Dev Biol. 2004;52(7):823–835. doi: 10.1387/ijdb.072444cb
   Google Scholar
• Thorel F, Népote V, Avril I, et al. Conversion of adult pancreatic α-cells to β-cells after extreme β-cell loss. Nature. 2010;464(7292):1149–1154. doi: 10.1038/nature08894
   PubMed Web of Science ®Google Scholar
• Wei R, Gu L, Yang J, et al. Antagonistic glucagon receptor antibody promotes α-cell proliferation and increases β-cell mass in diabetic mice. Iscience. 2019;16:326–339. doi: 10.1016/j.isci.2019.05.030
   PubMed Web of Science ®Google Scholar
• Steiner DJ, Kim A, Miller K, et al. Pancreatic islet plasticity: interspecies comparison of islet architecture and composition. Islets. 2010;2(3):135–145. doi: 10.4161/isl.2.3.11815
   PubMed Web of Science ®Google Scholar
• Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature. 2008;455(7213):627–632. doi: 10.1038/nature07314
   PubMed Web of Science ®Google Scholar
• Ariyachet C, Tovaglieri A, Xiang G, et al. Reprogrammed stomach tissue as a renewable source of functional β cells for blood glucose regulation. Cell Stem Cell. 2016;18(3):410–421. doi: 10.1016/j.stem.2016.01.003
   PubMed Web of Science ®Google Scholar
• Li W, Nakanishi M, Zumsteg A, et al. In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes. Elife. 2014;3:e01846. doi: 10.7554/eLife.01846
   PubMed Web of Science ®Google Scholar
• Gomez DL, O’Driscoll M, Sheets TP, et al. Neurogenin 3 expressing cells in the human exocrine pancreas have the capacity for endocrine cell fate. PLOS ONE. 2015;10(8):e0133862. doi: 10.1371/journal.pone.0133862
   PubMed Web of Science ®Google Scholar
• Keymeulen B, Walter M, Mathieu C, et al. Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia. 2010;53(4):614–623. doi: 10.1007/s00125-009-1644-9
   PubMed Web of Science ®Google Scholar
• Gitelman SE, Gottlieb PA, Rigby MR, et al. Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol. 2013;1(4):306–316. doi: 10.1016/S2213-8587(13)70065-2
   PubMed Web of Science ®Google Scholar
• Martin S, Pawlowski B, Greulich B, et al. Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care. 1992;15(1):66–74. doi: 10.2337/diacare.15.1.66
   PubMed Web of Science ®Google Scholar
• Barrett JC, Clayton DG, Concannon P, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nature Genet. 2009;41(6):703–707. doi: 10.1038/ng.381
   PubMed Web of Science ®Google Scholar
• Redondo MJ, Geyer S, Steck AK, et al. A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk. Diabetes Care. 2018;41(9):1887–1894. doi: 10.2337/dc18-0087
   PubMed Web of Science ®Google Scholar
• Krischer JP, Lynch KF, Lernmark Å, et al. Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY study. Diabetes Care. 2017;40(9):1194–1202. doi: 10.2337/dc17-0238
   PubMed Web of Science ®Google Scholar
• Battaglia M, Ahmed S, Anderson MS, et al. Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes. Diabetes Care. 2020;43(1):5–12. doi: 10.2337/dc19-0880
   PubMed Web of Science ®Google Scholar
• S.A. I. INNODIA is ready for a new phase - clinical trials. Belgium: Imcyse S.A. 2021 [cited 2021 May 31]. Available from: https://www.imcyse.com/contact.html
   Google Scholar
• Nepom GT, Ehlers M, Mandrup-Poulsen T. Anti-cytokine therapies in T1D: concepts and strategies. Clin Immunol. 2013;149(3):279–285. doi: 10.1016/j.clim.2013.02.003
   PubMed Web of Science ®Google Scholar
• Rosenzwajg M, Churlaud G, Mallone R, et al. Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients. J Autoimmun. 2015;58:48–58. doi: 10.1016/j.jaut.2015.01.001
   PubMed Web of Science ®Google Scholar
• dos Santos Haber JF, Barbalho SM, Sgarbi JA, et al. The relationship between type 1 diabetes mellitus, TNF-α, and IL-10 gene expression. Biomedicines. 2023;11(4):1120. doi: 10.3390/biomedicines11041120
   PubMed Web of Science ®Google Scholar
• Gouda W, Mageed L, Abd El Dayem SM, et al. Evaluation of pro-inflammatory and anti-inflammatory cytokines in type 1 diabetes mellitus. Bull National Res Centre. 2018;42(1):1–6. doi: 10.1186/s42269-018-0016-3
   Google Scholar
• Bluestone JA, Buckner JH, Fitch M, et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci Trans Med. 2015;7(315):ra315189–ra315189. doi: 10.1126/scitranslmed.aad4134
   Web of Science ®Google Scholar
• Leite NC, Pelayo GC, Melton DA. Genetic manipulation of stress pathways can protect stem-cell-derived islets from apoptosis in vitro. Stem Cell Rep. 2022;17(4):766–774. doi: 10.1016/j.stemcr.2022.01.018
   PubMed Web of Science ®Google Scholar
• Elvira B, Vandenbempt V, Bauzá-Martinez J, et al. PTPN2 regulates the interferon signaling and endoplasmic reticulum stress response in pancreatic β-cells in autoimmune diabetes. Diabetes. 2022;71(4):653–668. doi: 10.2337/db21-0443
   PubMed Web of Science ®Google Scholar
• Cai EP, Ishikawa Y, Zhang W, et al. Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes. Nat Metab. 2020;2(9):934–945. doi: 10.1038/s42255-020-0254-1
   PubMedGoogle Scholar
• Ludvigsson J, Sumnik Z, Pelikanova T, et al. Intralymphatic glutamic acid decarboxylase with vitamin D supplementation in recent-onset type 1 diabetes: a double-blind, randomized, placebo-controlled phase IIb trial. Diabetes Care. 2021;44(7):1604–1612. doi: 10.2337/dc21-0318
   PubMed Web of Science ®Google Scholar
• Roep BO, Solvason N, Gottlieb PA, et al. Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8(+) T cells in type 1 diabetes. Sci Transl Med. 2013 Jun 26;5(191):191ra82. doi: 10.1126/scitranslmed.3006103
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155(3):1151–1164. doi: 10.4049/jimmunol.155.3.1151
   PubMed Web of Science ®Google Scholar
• Raffin C, Vo LT, Bluestone JA. Treg cell-based therapies: challenges and perspectives. Nat Rev Immunol. 2020;20(3):158–172. doi: 10.1038/s41577-019-0232-6
   PubMed Web of Science ®Google Scholar
• Wright GP, Notley CA, Xue S-A, et al. Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Proc Nat Acad Sci. 2009;106(45):19078–19083. doi: 10.1073/pnas.0907396106
   PubMed Web of Science ®Google Scholar
• Fujio K, Okamoto A, Araki Y, et al. Gene therapy of arthritis with TCR isolated from the inflamed paw. J Immunol. 2006;177(11):8140–8147. doi: 10.4049/jimmunol.177.11.8140
   PubMed Web of Science ®Google Scholar
• Zhou P, Borojevic R, Streutker C, et al. Expression of dual TCR on DO11. 10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens. J Immunol. 2004;172(3):1515–1523. doi: 10.4049/jimmunol.172.3.1515
   PubMed Web of Science ®Google Scholar
• Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood J Am Soc Hematology. 2011;117(3):1061–1070. doi: 10.1182/blood-2010-07-293795
   Google Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775–787. doi: 10.1016/j.cell.2008.05.009
   PubMed Web of Science ®Google Scholar
• Hippen KL, Merkel SC, Schirm DK, et al. Massive ex vivo expansion of human natural regulatory T cells (tregs) with minimal loss of in vivo functional activity. Sci Trans Med. 2011;3(83):ra8341–ra8341. doi: 10.1126/scitranslmed.3001809
   Web of Science ®Google Scholar
• Yang SJ, Singh AK, Drow T, et al. Pancreatic islet-specific engineered tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models. Sci Trans Med. 2022;14(665):eabn1716. doi: 10.1126/scitranslmed.abn1716
   PubMed Web of Science ®Google Scholar
• Chen JS, Doudna JA. The chemistry of Cas9 and its CRISPR colleagues. Nat Rev chem. 2017;1(10):1–15. doi: 10.1038/s41570-017-0078
   Web of Science ®Google Scholar
• Kopp JL, Grompe M, Sander M. Stem cells versus plasticity in liver and pancreas regeneration. Nat Cell Biol. 2016;18(3):238–245. doi: 10.1038/ncb3309
   PubMed Web of Science ®Google Scholar
• Gimenez CA, Ielpi M, Mutto A, et al. CRISPR-on system for the activation of the endogenous human INS gene. Gene Ther. 2016 Jun;23:(6):543–547.
   PubMed Web of Science ®Google Scholar
• Ma S, Viola R, Sui L, et al. Beta cell replacement after gene editing of a neonatal diabetes-causing mutation at the insulin locus. Stem Cell Rep. 2018 Dec 11;11(6):1407–1415. doi: 10.1016/j.stemcr.2018.11.006
   PubMed Web of Science ®Google Scholar
• Yang L, Guell M, Niu D, et al. Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Science. 2015 Nov 27;350(6264):1101–1104. doi: 10.1126/science.aad1191
   PubMed Web of Science ®Google Scholar
• Wherrett DK, Bundy B, Becker DJ, et al. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. Lancet. 2011;378(9788):319–327. doi: 10.1016/S0140-6736(11)60895-7
   PubMed Web of Science ®Google Scholar
• Hughes JW, Riddlesworth TD, DiMeglio LA, et al. Autoimmune diseases in children and adults with type 1 diabetes from the T1D exchange clinic registry. J Clin Endocrinol Metab. 2016;101(12):4931–4937. doi: 10.1210/jc.2016-2478
   PubMed Web of Science ®Google Scholar
• Khadilkar A, Oza C. Glycaemic control in youth and young adults: challenges and solutions. Diabetes, metabolic syndrome and obesity: targets and therapy. 2022;Volume 15:121–129. doi: 10.2147/DMSO.S304347
   Google Scholar
• Lind M, Svensson A-M, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371(21):1972–1982. doi: 10.1056/NEJMoa1408214
   PubMed Web of Science ®Google Scholar
• Nellore A, Fishman JA. The microbiome, systemic immune function, and allotransplantation. Clin Microbiol Rev. 2016;29(1):191–199. doi: 10.1128/CMR.00063-15
   PubMed Web of Science ®Google Scholar
• Fishman J. Infection in organ transplantation. Am J Transplant. 2017;17(4):856–879. doi: 10.1111/ajt.14208
   PubMed Web of Science ®Google Scholar
• Shen Y, Lian D, Shi K, et al. Cancer risk and mutational patterns following organ transplantation. Front Cell Dev Biol. 2022;10:10. doi: 10.3389/fcell.2022.956334
   Web of Science ®Google Scholar
• Ali M, Kato Y, Shiraki N, et al. Generation of induced pluripotent stem cell-derived beta-cells in blood amino acids-like medium. Biol Open. 2023;12(3):bio059581. doi: 10.1242/bio.059581
   PubMed Web of Science ®Google Scholar
• Balboa D, Barsby T, Lithovius V, et al. Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nature Biotechnol. 2022;40(7):1042–1055. doi: 10.1038/s41587-022-01219-z
   PubMed Web of Science ®Google Scholar
• Aigha II, Abdelalim EM. p53 inhibition in pancreatic progenitors enhances the differentiation of human pluripotent stem cells into pancreatic β-cells. Stem Cell Rev Rep. 2023;19(4):1–11. doi: 10.1007/s12015-023-10509-1
   PubMed Web of Science ®Google Scholar
• Näntö-Salonen K, Kupila A, Simell S, et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet. 2008;372(9651):1746–1755. doi: 10.1016/S0140-6736(08)61309-4
   PubMed Web of Science ®Google Scholar
• Ludvigsson J, Faresjö M, Hjorth M, et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med. 2008;359(18):1909–1920. doi: 10.1056/NEJMoa0804328
   PubMed Web of Science ®Google Scholar